Literature DB >> 10352000

Contribution of the TATA-box genotype (Gilbert syndrome) to serum bilirubin concentrations in the Italian population.

M L Biondi1, O Turri, D Dilillo, G Stival, E Guagnellini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10352000

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.

Authors:  Shabana Farheen; Sanghamitra Sengupta; Amal Santra; Suparna Pal; Gopal Krishna Dhali; Meenakshi Chakravorty; Partha P Majumder; Abhijit Chowdhury
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

2.  The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.

Authors:  Suad AlFadhli; Hassan Al-Jafer; Mays Hadi; Mashael Al-Mutairi; Rasheeba Nizam
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

3.  Mechanism of indinavir-induced hyperbilirubinemia.

Authors:  S D Zucker; X Qin; S D Rouster; F Yu; R M Green; P Keshavan; J Feinberg; K E Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

Review 4.  The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions.

Authors:  Sara Correia Marques; Ogechi N Ikediobi
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

5.  UGT1A1 (TA)n Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia.

Authors:  M Vukovic; N Radlovic; Z Lekovic; K Vucicevic; N Maric; N Kotur; V Gasic; M Ugrin; M Stojiljkovic; L Dokmanovic; B Zukic; S Pavlovic
Journal:  Balkan J Med Genet       Date:  2018-10-29       Impact factor: 0.519

6.  Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study.

Authors:  Setor K Kunutsor; Monika Frysz; Niek Verweij; Lyanne M Kieneker; Stephan J L Bakker; Robin P F Dullaart
Journal:  Eur J Epidemiol       Date:  2019-11-26       Impact factor: 8.082
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.